Fagron Reports 10.3% Q1 Revenue Growth

Fagron posted Q1 2026 revenue of €263.4 million, up 10.3% YoY, with organic growth of 3.2% at constant exchange rates.
Latin America delivered 10.4% organic growth, driven by the Brands strategy in Brazil, while EMEA also contributed to topline expansion.
The company completed its acquisition of Dutch firm Pharmavit during the quarter, with integration on track and supporting revenue growth.
For FY 2026, Fagron forecasts mid‑ to high‑single‑digit organic sales growth and a REBITDA margin around 20%, expecting stronger second‑half performance.